Probing gut‐brain links in Alzheimer's disease with rifaximin

Probing gut‐brain links in Alzheimer's disease with rifaximin

Abstract Gut‐microbiome‐inflammation interactions have been linked to neurodegeneration in Alzheimer's disease (AD) and other disorders. We hypothesized that treatment with rifaximin, a minimally absorbed gut‐specific antibiotic, may modify the neurodegenerative process by changing gut flora an...

Full description

Bibliographic Details
Main Authors: Paul V. Suhocki, James S. Ronald, Anna Mae E. Diehl, David M. Murdoch, P. Murali Doraiswamy
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Alzheimer’s & Dementia: Translational Research & Clinical Interventions
Subjects:
antibiotics
microbiome
neurodegenerative disorders
probiotics
Online Access:https://doi.org/10.1002/trc2.12225

Internet

https://doi.org/10.1002/trc2.12225

Similar Items